| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 1.38e-04 | 105 | 50 | 4 | GO:0004867 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 2.19e-04 | 9 | 50 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 8.45e-04 | 74 | 50 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.06e-03 | 180 | 50 | 4 | GO:0004866 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 1.13e-03 | 20 | 50 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 1.13e-03 | 20 | 50 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.23e-03 | 187 | 50 | 4 | GO:0030414 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.38e-03 | 193 | 50 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.45e-03 | 334 | 50 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.48e-03 | 197 | 50 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 1.50e-03 | 23 | 50 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.60e-03 | 201 | 50 | 4 | GO:0061135 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 1.92e-03 | 26 | 50 | 2 | GO:0052742 | |
| GeneOntologyBiologicalProcess | calcium activated phosphatidylserine scrambling | 3.73e-05 | 4 | 52 | 2 | GO:0061589 | |
| GeneOntologyBiologicalProcess | calcium activated phospholipid scrambling | 6.20e-05 | 5 | 52 | 2 | GO:0061588 | |
| GeneOntologyBiologicalProcess | calcium activated phosphatidylcholine scrambling | 6.20e-05 | 5 | 52 | 2 | GO:0061590 | |
| GeneOntologyBiologicalProcess | calcium activated galactosylceramide scrambling | 6.20e-05 | 5 | 52 | 2 | GO:0061591 | |
| MousePheno | abnormal calcium ion homeostasis | 1.55e-05 | 404 | 40 | 8 | MP:0004231 | |
| Domain | Serpin_CS | 8.48e-05 | 32 | 50 | 3 | IPR023795 | |
| Domain | Serpin_dom | 1.21e-04 | 36 | 50 | 3 | IPR023796 | |
| Domain | SERPIN | 1.32e-04 | 37 | 50 | 3 | SM00093 | |
| Domain | SERPIN | 1.32e-04 | 37 | 50 | 3 | PS00284 | |
| Domain | Serpin | 1.43e-04 | 38 | 50 | 3 | PF00079 | |
| Domain | Anoct_dimer | 1.46e-04 | 7 | 50 | 2 | PF16178 | |
| Domain | Anoct_dimer | 1.46e-04 | 7 | 50 | 2 | IPR032394 | |
| Domain | Mob1_phocein | 1.46e-04 | 7 | 50 | 2 | PF03637 | |
| Domain | MOB_kinase_act_fam | 1.46e-04 | 7 | 50 | 2 | IPR005301 | |
| Domain | - | 1.46e-04 | 7 | 50 | 2 | 1.20.140.30 | |
| Domain | Mob1_phocein | 1.46e-04 | 7 | 50 | 2 | SM01388 | |
| Domain | Serpin_fam | 1.54e-04 | 39 | 50 | 3 | IPR000215 | |
| Domain | Anoctamin | 3.12e-04 | 10 | 50 | 2 | PF04547 | |
| Domain | Anoctamin | 3.12e-04 | 10 | 50 | 2 | IPR007632 | |
| Domain | ANF_lig-bd_rcpt | 4.41e-03 | 37 | 50 | 2 | IPR001828 | |
| Domain | ANF_receptor | 4.41e-03 | 37 | 50 | 2 | PF01094 | |
| Domain | Peripla_BP_I | 4.89e-03 | 39 | 50 | 2 | IPR028082 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 30349003 | ||
| Pubmed | Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. | 2.28e-06 | 2 | 53 | 2 | 23143302 | |
| Pubmed | Human Mob1 proteins are required for cytokinesis by controlling microtubule stability. | 2.28e-06 | 2 | 53 | 2 | 22454515 | |
| Pubmed | EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1. | 6.83e-06 | 3 | 53 | 2 | 34725466 | |
| Pubmed | The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. | 6.83e-06 | 3 | 53 | 2 | 16674920 | |
| Pubmed | PTEN-GSK3β-MOB1 axis controls neurite outgrowth in vitro and in vivo. | 1.36e-05 | 4 | 53 | 2 | 30069702 | |
| Pubmed | Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. | 1.36e-05 | 4 | 53 | 2 | 15197186 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 31066578 | ||
| Pubmed | The transcription factor GATA-4 regulates cytochrome P4502C19 gene expression. | 2.27e-05 | 5 | 53 | 2 | 20206639 | |
| Pubmed | YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma. | 2.27e-05 | 5 | 53 | 2 | 32206709 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 35858357 | ||
| Pubmed | Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice. | 3.40e-05 | 6 | 53 | 2 | 32716083 | |
| Pubmed | YAP determines the cell fate of injured mouse hepatocytes in vivo. | 3.40e-05 | 6 | 53 | 2 | 28681838 | |
| Pubmed | 3.95e-05 | 43 | 53 | 3 | 24172014 | ||
| Pubmed | MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. | 4.76e-05 | 7 | 53 | 2 | 18328708 | |
| Pubmed | ANOs 3-7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins. | 4.76e-05 | 7 | 53 | 2 | 22075693 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 19739119 | ||
| Pubmed | Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. | 6.34e-05 | 8 | 53 | 2 | 26699479 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 22946059 | ||
| Pubmed | Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels. | 1.02e-04 | 10 | 53 | 2 | 19015192 | |
| Pubmed | Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. | 1.02e-04 | 10 | 53 | 2 | 23532839 | |
| Pubmed | 1.02e-04 | 10 | 53 | 2 | 24692353 | ||
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 15203215 | ||
| Pubmed | 2.05e-04 | 14 | 53 | 2 | 31806350 | ||
| Pubmed | A genome-wide association study on obesity and obesity-related traits. | 2.36e-04 | 15 | 53 | 2 | 21552555 | |
| Pubmed | 3.43e-04 | 18 | 53 | 2 | 28346423 | ||
| Pubmed | Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development. | 8.40e-04 | 28 | 53 | 2 | 37846569 | |
| Pubmed | Alternatively spliced isoforms of WT1 control podocyte-specific gene expression. | 8.40e-04 | 28 | 53 | 2 | 25993318 | |
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 1.10e-03 | 32 | 53 | 2 | 22424883 | |
| Cytoband | 8q22 | 1.36e-04 | 15 | 53 | 2 | 8q22 | |
| Cytoband | 10p14 | 4.18e-04 | 26 | 53 | 2 | 10p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8q22 | 9.86e-04 | 168 | 53 | 3 | chr8q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p14 | 1.49e-03 | 49 | 53 | 2 | chr10p14 | |
| GeneFamily | Serpin peptidase inhibitors | 5.38e-05 | 37 | 36 | 3 | 739 | |
| GeneFamily | MOB kinase activators|STRIPAK complex | 8.04e-05 | 7 | 36 | 2 | 647 | |
| GeneFamily | Anoctamins | 1.72e-04 | 10 | 36 | 2 | 865 | |
| Disease | lysosomal protective protein measurement | 6.12e-05 | 7 | 51 | 2 | EFO_0008215 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 6.02e-04 | 21 | 51 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 7.24e-04 | 23 | 51 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | unipolar depression, neuroticism measurement | 7.89e-04 | 24 | 51 | 2 | EFO_0003761, EFO_0007660 | |
| Disease | seasonal gut microbiome measurement | 9.71e-04 | 112 | 51 | 3 | EFO_0007753 | |
| Disease | factor XI measurement, venous thromboembolism | 1.24e-03 | 30 | 51 | 2 | EFO_0004286, EFO_0004694 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.59e-03 | 34 | 51 | 2 | EFO_0004286, EFO_0004630 | |
| Disease | granulocyte colony-stimulating factor measurement | 1.59e-03 | 34 | 51 | 2 | EFO_0008142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRFQNIFTTIFTLFT | 611 | Q8NEC5 | |
| KAAQQRSFHFQSFRE | 1306 | P16157 | |
| HNSKNQFFTIFFFLS | 11 | Q99440 | |
| FVAFTNHFKQVFSDV | 911 | P11532 | |
| SKFAQFRRLNFAQIH | 1961 | P11532 | |
| FIIHNKETFFNNATR | 246 | Q32M45 | |
| QDTFFTSTKRHQILF | 246 | Q6IWH7 | |
| LQITRISAFFQHFQN | 56 | P23352 | |
| SFFLSHDQRFFLKTQ | 141 | Q5T9C9 | |
| QFFQKLRNKHEFTIL | 76 | Q99435 | |
| SVQGFKEALFQFFHN | 281 | Q9UHH9 | |
| DTFFFILRKNNHQIT | 126 | Q9NYP7 | |
| FSVHSCFFNFQVRKI | 166 | Q8N7Q2 | |
| NRFHFKLTDQTNNRF | 181 | O43451 | |
| FLNVAIFQHFKSLID | 26 | Q8NCR3 | |
| IQFNNLSNFITHKKF | 1126 | Q8WW38 | |
| SIATKFNFFIHNLAQ | 1381 | O00443 | |
| KFTHNHFQFFVSENL | 571 | Q9HC56 | |
| FHQLLQTFNFRKLQC | 181 | Q8IXT1 | |
| TFHVFSRLFQTIQRK | 2706 | O94915 | |
| ITLIFNKFSHFYRRQ | 406 | Q9ULS6 | |
| TSFKHFIFFVQEFNL | 181 | Q7L9L4 | |
| FQRKTQFLFERTFNL | 356 | Q8IZP7 | |
| NFIQKQEKRIFTNFH | 211 | P48739 | |
| LFTFNHFNDFVNAIK | 741 | Q8IWW6 | |
| FVLFKNATAFHVTVQ | 21 | Q16827 | |
| VFLRQFHVFDLFNKA | 276 | Q5T6X5 | |
| HRAFSVFLFNTENKL | 51 | Q13907 | |
| FLFLTFILQNFNLKS | 446 | P33261 | |
| FFHVAFQGKDILSFQ | 131 | P15813 | |
| FFQAKHLIERSQVFN | 86 | Q9NZK5 | |
| FFLLFQFCTHINFQK | 116 | Q96LL3 | |
| FVKFQFQRFTTLNLH | 126 | Q16099 | |
| QAVFYTFVFRHKQLL | 461 | Q9NYV6 | |
| ANFSNFIFLHLKRRV | 111 | P59537 | |
| KFFSAQTNRHILRFN | 386 | P29622 | |
| TSFKHFIFFVQEFNL | 181 | Q9H8S9 | |
| ITTTKQQDHFFQAAF | 71 | P08567 | |
| FFIRHNKTQTILFYG | 386 | Q96P63 | |
| SFNTSLFKQTFQRVF | 376 | Q15436 | |
| LLFVRHQFKIAFFSE | 221 | Q7Z392 | |
| FNHRIKEVLFNSLFS | 281 | Q9NV64 | |
| SVTKVFNNHFFQVTI | 321 | Q5VUG0 | |
| LFHFQDKLTARQFQR | 381 | Q9C0B7 | |
| VQISFFSVKTHIFNN | 161 | Q76KX8 | |
| NDFFNSFTTVLHKQR | 1396 | Q92576 | |
| QAVFYTFVFRHKQLL | 86 | Q2M238 | |
| RIHIFSSFFYKRLNQ | 706 | Q9GZR1 | |
| TSFHRFFFTANQVKI | 146 | Q9BQ65 | |
| FFHSLFTQNKQLQRV | 41 | Q9UFB7 | |
| LQQHFILRFRAFQQS | 356 | Q6NUS6 | |
| NQFVVHTVQFLNRFS | 31 | Q9Y3C0 | |
| FAEAHQVLFTFNLKS | 846 | Q68DK2 | |
| ELNTFFLKHIFVFQA | 301 | P48651 | |
| LFLSNVFHKAFVEIN | 331 | P48595 | |
| FLFFIRHNKTNTILF | 376 | P48595 | |
| ATFFQVFSQLHELRQ | 1426 | Q562E7 |